Author

Eva Papachristou

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Clive S. D’SantosiD· 2 shared Alexander J. T. WoodiD· 1 shared Andrew Conway MorrisiD· 1 shared Ashley Dawn Smith· 1 shared Danish MemoniD· 1 shared David OchoaiD· 1 shared David ThomasiD· 1 shared Helena Brown· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Clive S. D’SantosORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Temporal phosphoproteomic programmes set a redox-gated rheostat on neutrophil phagocytosis

Maire Röder, Muhammad Iqbal, Ng Anthony Yong Kheng Cordero, Helena Brown, Iat Tai Wong, Samuel Lewirt, Motaharehsadat Heydarian, Ashley Dawn Smith, Isabella M Monsanto, Mengye Li, Alexander J. T. Wood, Matthew Routledge, Kamal Kishore, Clive S. D’Santos, Eva Papachristou, , Andrew Conway Morris

This paper identifies a redox-gated phagocytic rheostat in neutrophils by analyzing phosphoproteomic and functional responses to bacterial exposure.

bioRxiv · Oct 28, 2026 · PreprintImmunology

Copy number aberrations drive kinase re-wiring leading to genetic vulnerabilities in cancer

Danish Memon, Michael B. Gill, Eva Papachristou, David Ochoa, Clive S. D’Santos, Martin L. Miller, Pedro Beltrão

The paper identifies copy number aberrations that alter kinase signaling and highlights potential therapeutic targets by integrating genomic and proteomic data across cancer samples.

bioRxiv · Jan 9, 2019 · PreprintGenomics